Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for DArecca James
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-08-12
Sale
2021-08-12
9:33 pm
TherapeuticsMD Inc.TXMDDArecca James
Chief Financial Officer
93,337$0.87$81,203558,163
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-08-01
Option Award
2023-08-03
2:01 pm
N/A
N/A
Prestige Consumer Healthcare Inc.PBHDArecca James
Director
2,295$02,295
(Direct)
View
2023-05-15
Option Award
2023-05-17
4:26 pm
N/A
2030-05-15
HAEMONETICS CORPHAEDArecca James
EVP, Chief Financial Officer
13,707$023,604
(Direct)
View
2023-05-16
Tax Withholding
2023-05-17
4:26 pm
N/A
N/A
HAEMONETICS CORPHAEDArecca James
EVP, Chief Financial Officer
349$89.2123,604
(Direct)
View
2023-05-02
Tax Withholding
2023-05-04
4:27 pm
N/A
N/A
HAEMONETICS CORPHAEDArecca James
EVP, Chief Financial Officer
430$81.6610,246
(Direct)
View
2022-05-16
Option Award
2022-05-18
4:34 pm
N/A
2029-05-16
HAEMONETICS CORPHAEDArecca James
EVP, Chief Financial Officer
15,937$021,839
(Direct)
View
2022-05-02
Option Award
2022-05-04
4:41 pm
N/A
2029-05-02
HAEMONETICS CORPHAEDArecca James
EVP, Chief Financial Officer
19,730$019,730
(Direct)
View
2021-08-10
Exercise
2021-08-12
9:33 pm
N/A
N/A
TherapeuticsMD Inc.TXMDDArecca James
Chief Financial Officer
217,167$0558,163
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:45 pm
N/A
N/A
TherapeuticsMD Inc.TXMDDArecca James
CFO
520,000$0520,000
(Direct)
View
2020-06-18
Option Award(A)
2020-08-07
9:16 pm
N/A
N/A
TherapeuticsMD Inc.TXMDDArecca James
Chief Financial Officer
803,000$0803,000
(Direct)
View
2020-06-18
Option Award
2020-06-19
5:07 pm
N/A
N/A
TherapeuticsMD Inc.TXMDDArecca James
Chief Financial Officer
803,000$0803,000
(Direct)
View
2020-05-08
Disposition
2020-05-11
9:50 pm
N/A
2023-07-17
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
19,495$00
(Direct)
View
2020-03-06
Tax Withholding
2020-03-10
2:10 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
718$191.959,834
(Direct)
View
2020-03-02
Option Award
2020-03-04
2:22 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
3,611$193.8410,552
(Direct)
View
2019-12-31
Tax Withholding
2020-01-02
5:52 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
92$191.176,941
(Direct)
View
2019-03-07
Tax Withholding
2019-03-11
5:49 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
359$1437,033
(Direct)
View
2019-03-08
Tax Withholding
2019-03-11
5:49 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
113$145.067,033
(Direct)
View
2019-03-06
Option Award
2019-03-08
3:27 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
2,036$137.517,505
(Direct)
View
2019-03-04
Tax Withholding
2019-03-06
3:49 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
114$139.125,469
(Direct)
View
2018-12-31
Tax Withholding
2019-01-03
3:50 pm
N/A
N/A
Allergan plcAGNDArecca James
SVP Chief Accounting Officer
147$133.665,453
(Direct)
View
(A) Indicate amendment filing.